{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:19:36Z","timestamp":1790745576231,"version":"4.1.0"},"reference-count":63,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2022.0244","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T07:01:29Z","timestamp":1659078089000},"source":"Crossref","is-referenced-by-count":73,"title":["The use of psychoactive substances in Germany"],"prefix":"10.3238","author":[{"given":"Christian","family":"Rauschert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"M\u00f6ckl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicki-Nils","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Wilms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Olderbak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig","family":"Kraus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2022,8,8]]},"reference":[{"key":"10.3238\/arztebl.m2022.0244_ref1","doi-asserted-by":"crossref","unstructured":"Peacock A, Leung J, Larney S, et al.: Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction 2018; 113: 1905\u201326","DOI":"10.1111\/add.14234"},{"key":"10.3238\/arztebl.m2022.0244_ref2","unstructured":"GBD 2019 Risk Factors Collaborators: Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396: 1223\u201349"},{"key":"10.3238\/arztebl.m2022.0244_ref3","unstructured":"Institute for Health Metrics and Evaluation: Global Health Data Exchange GHDx, GBD Results Tool Permalink. https:\/\/vizhub.healthdata.org\/gbd-results?params=gbd-api-2019-permalink\/a1edd84cef44a2d98889bb6e5774c5d3 (last accessed on 10 February 2022)."},{"key":"10.3238\/arztebl.m2022.0244_ref4","doi-asserted-by":"crossref","unstructured":"Manthey J, Shield KD, Rylett M, Hasan OSM, Probst C, Rehm J: Global alcohol exposure between 1990 and 2017 and forecasts until 2030: a modelling study. Lancet 2019; 393: 2493\u2013502","DOI":"10.1016\/S0140-6736(18)32744-2"},{"key":"10.3238\/arztebl.m2022.0244_ref5","doi-asserted-by":"crossref","unstructured":"Seitz NN, Lochb\u00fchler K, Atzendorf J, Rauschert C, Pfeiffer-Gerschel T, Kraus L: Trends in substance use and related disorders\u2014analysis of the Epidemiological Survey of Substance Abuse 1995 to 2018. Dtsch Arztebl Int 2019; 116: 585\u201391","DOI":"10.3238\/arztebl.2019.0585"},{"key":"10.3238\/arztebl.m2022.0244_ref6","doi-asserted-by":"crossref","unstructured":"Reitsma MB, Kendrick PJ, Ababneh E, et al.: Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990\u20132019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet 2021; 397: 2337\u201360","DOI":"10.1016\/S0140-6736(21)01169-7"},{"key":"10.3238\/arztebl.m2022.0244_ref7","unstructured":"Effertz T: Die volkswirtschaftlichen Kosten von Alkohol-und Tabakkonsum in Deutschland. In: Deutsche Hauptstelle f\u00fcr Suchtfragen (ed.): Jahrbuch Sucht. Lengerich: Pabst 2020; 225\u201334."},{"key":"10.3238\/arztebl.m2022.0244_ref8","doi-asserted-by":"crossref","unstructured":"Mostardt S, Fl\u00f6ter S, Neumann A, Wasem J, Pfeiffer-Gerschel T: Sch\u00e4tzung der Ausgaben der \u00f6ffentlichen Hand durch den Konsum illegaler Drogen in Deutschland. Das Gesundheitswesen 2010; 72: 886\u201394","DOI":"10.1055\/s-0029-1243212"},{"key":"10.3238\/arztebl.m2022.0244_ref9","doi-asserted-by":"crossref","unstructured":"Effertz T, Verheyen F, Linder R: \u00d6konomische und intangible Kosten des Cannabiskonsums in Deutschland. Sucht 2016; 62: 31\u201341","DOI":"10.1024\/0939-5911\/a000406"},{"key":"10.3238\/arztebl.m2022.0244_ref10","unstructured":"World Health Organization: Guidelines for controlling and monitoring the tobacco epidemic. Geneva: WHO 1998."},{"key":"10.3238\/arztebl.m2022.0244_ref11","doi-asserted-by":"crossref","unstructured":"Burger M, Br\u00f6nstrup A, Pietrzik K: Derivation of tolerable upper alcohol intake levels in Germany: a systematic review of risks and benefits of moderate alcohol consumption. Prev Med 2004; 39: 111\u201327","DOI":"10.1016\/j.ypmed.2003.11.011"},{"key":"10.3238\/arztebl.m2022.0244_ref12","unstructured":"Seitz H, B\u00fchringer G, Mann K: Grenzwerte f\u00fcr den Konsum alkoholischer Getr\u00e4nke. Jahrbuch Sucht 2008; 7: 205\u20139."},{"key":"10.3238\/arztebl.m2022.0244_ref13","unstructured":"European Commission: Special Eurobarometer 506: Attitudes of Europeans towards tobacco and electronic cigarettes. 2021. Europa.eu\/eurobarometer\/surveys\/detail\/2240 (last accessed on 21 June 2022)."},{"key":"10.3238\/arztebl.m2022.0244_ref14","unstructured":"DEBRA. Deutsche Befragung zum Rauchverhalten. www.debra-study.info\/ (last accessed on 15 March 2022)."},{"key":"10.3238\/arztebl.m2022.0244_ref15","doi-asserted-by":"crossref","unstructured":"Mons U, Brenner H: Demographic ageing and the evolution of smoking-attributable mortality: the example of Germany. Tob Control 2017; 26: 455","DOI":"10.1136\/tobaccocontrol-2016-053008"},{"key":"10.3238\/arztebl.m2022.0244_ref16","unstructured":"Kotz D, Batra A, Kastaun S: Smoking cessation attempts and common strategies employed\u2014a Germany-wide representative survey conducted in 19 waves from 2016 to 2019 (The DEBRA Study) and analyzed by socioeconomic status. Dtsch Arztebl Int 2020; 117: 7\u201313."},{"key":"10.3238\/arztebl.m2022.0244_ref17","unstructured":"National Academies of Sciences, Engineering, and Medicine: Public Health Consequences of E-Cigarettes. Washington, DC: The National Academies Press; 2018."},{"key":"10.3238\/arztebl.m2022.0244_ref18","doi-asserted-by":"crossref","unstructured":"Keith R, Bhatnagar A: Cardiorespiratory and immunologic effects of electronic cigarettes. Curr Addict Rep 2021; 8: 336\u201346","DOI":"10.1007\/s40429-021-00359-7"},{"key":"10.3238\/arztebl.m2022.0244_ref19","doi-asserted-by":"crossref","unstructured":"Sapru S, Vardhan M, Li Q, Guo Y, Li X, Saxena D: E-cigarettes use in the United States: reasons for use, perceptions, and effects on health. BMC Public Health 2020; 20: 1518","DOI":"10.1186\/s12889-020-09572-x"},{"key":"10.3238\/arztebl.m2022.0244_ref20","doi-asserted-by":"crossref","unstructured":"Kraus L, M\u00f6ckl J, Rauschert C, Seitz NN, Lochb\u00fchler K, Olderbak S: Changes in the use of tobacco, alternative tobacco products, and tobacco alternatives in Germany. Dtsch Arztebl Int 2022; 117: 535\u20134","DOI":"10.3238\/arztebl.m2022.0252"},{"key":"10.3238\/arztebl.m2022.0244_ref21","doi-asserted-by":"crossref","unstructured":"Smyth A, Teo KK, Rangarajan S, et al.: Alcohol consumption and cardiovascular disease, cancer, injury, admission to hospital, and mortality: a prospective cohort study. Lancet 2015; 386: 1945\u201354","DOI":"10.1016\/S0140-6736(15)00235-4"},{"key":"10.3238\/arztebl.m2022.0244_ref22","doi-asserted-by":"crossref","unstructured":"Kraus L, Seitz NN, Shield KD, Gmel G, Rehm J: Quantifying harms to others due to alcohol consumption in Germany: a register-based study. BMC Med 2019; 17: 59","DOI":"10.1186\/s12916-019-1290-0"},{"key":"10.3238\/arztebl.m2022.0244_ref23","doi-asserted-by":"crossref","unstructured":"Hermens DF, Lagopoulos J: Binge drinking and the young brain: a mini review of the neurobiological underpinnings of alcohol-induced blackout. Front Psychol 2018; 9: 12","DOI":"10.3389\/fpsyg.2018.00012"},{"key":"10.3238\/arztebl.m2022.0244_ref24","doi-asserted-by":"crossref","unstructured":"Yuen WS, Chan G, Bruno R, et al.: Trajectories of alcohol-induced blackouts in adolescence: early risk factors and alcohol use disorder outcomes in early adulthood. Addiction 2021; 116: 2039\u201348","DOI":"10.1111\/add.15415"},{"key":"10.3238\/arztebl.m2022.0244_ref25","doi-asserted-by":"crossref","unstructured":"Garnett C, Kastaun S, Brown J, Kotz D: Alcohol consumption and associations with sociodemographic and health-related characteristics in Germany: a population survey. Addict Behav 2022; 125: 107159","DOI":"10.1016\/j.addbeh.2021.107159"},{"key":"10.3238\/arztebl.m2022.0244_ref26","doi-asserted-by":"crossref","unstructured":"Manthey J, Freeman TP, Kilian C, L\u00f3pez-Pelayo H, Rehm J: Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment rates. Lancet Reg Health Eur 2021; 10: 100227","DOI":"10.1016\/j.lanepe.2021.100227"},{"key":"10.3238\/arztebl.m2022.0244_ref27","doi-asserted-by":"crossref","unstructured":"Atzendorf J, Rauschert C, Seitz NN, Lochb\u00fchler K, Kraus L: The use of alcohol, tobacco, illegal drugs and medicines\u2014an estimate of consumption and substance-related disorders in Germany. Dtsch Arztebl Int 2019; 116: 577\u201384","DOI":"10.3238\/arztebl.2019.0577"},{"key":"10.3238\/arztebl.m2022.0244_ref28","doi-asserted-by":"crossref","unstructured":"Mitteilungen des BDE. Der Diabetologe 2022; 18: 90\u20132","DOI":"10.1007\/s11428-021-00844-7"},{"key":"10.3238\/arztebl.m2022.0244_ref29","doi-asserted-by":"crossref","unstructured":"Gahr M, Ziller J, Keller F, Muche R, Preuss UW, Sch\u00f6nfeldt-Lecuona C: Incidence of inpatient cases with mental disorders due to use of cannabinoids in Germany: a nationwide evaluation. Eur J Public Health 2022; 32: 239\u201345","DOI":"10.1093\/eurpub\/ckab207"},{"key":"10.3238\/arztebl.m2022.0244_ref30","doi-asserted-by":"crossref","unstructured":"Hobbs M, Kalk NJ, Morrison PD, Stone JM: Spicing it up-synthetic cannabinoid receptor agonists and psychosis\u2014 a systematic review. Eur Neuropsychopharmacol 2018; 28: 1289\u2013304","DOI":"10.1016\/j.euroneuro.2018.10.004"},{"key":"10.3238\/arztebl.m2022.0244_ref31","doi-asserted-by":"crossref","unstructured":"Lorenzetti V, Hoch E, Hall W: Adolescent cannabis use, cognition, brain health and educational outcomes: a review of the evidence. Eur Neuropsychopharmacol 2020; 36: 169\u201380","DOI":"10.1016\/j.euroneuro.2020.03.012"},{"key":"10.3238\/arztebl.m2022.0244_ref32","doi-asserted-by":"crossref","unstructured":"Cyrus E, Coudray MS, Kiplagat S, et al.: A review investigating the relationship between cannabis use and adolescent cognitive functioning. Curr Opin Psychol 2021; 38: 38\u201348","DOI":"10.1016\/j.copsyc.2020.07.006"},{"key":"10.3238\/arztebl.m2022.0244_ref33","unstructured":"Europ\u00e4ische Beobachtungsstelle f\u00fcr Drogen und Drogensucht (EMCDDA): Europ\u00e4ischer Drogenbericht 2021: Trends und Entwicklungen. Luxemburg: Amt f\u00fcr Ver\u00f6ffentlichungen der Europ\u00e4ischen Union 2021. www.pvtweb.de\/fileadmin\/user_upload-\/Dateien_zum_Download\/Europ_Drogenbericht_2021_2021.2256_DE0906.pdf (last accessed on 21 June 2022)."},{"key":"10.3238\/arztebl.m2022.0244_ref34","doi-asserted-by":"crossref","unstructured":"Fendrick AM, Pan DE, Johnson GE: OTC analgesics and drug interactions: clinical implications. Osteopath Med Prim Care 2008; 2: 2","DOI":"10.1186\/1750-4732-2-2"},{"key":"10.3238\/arztebl.m2022.0244_ref35","doi-asserted-by":"crossref","unstructured":"Bindu S, Mazumder S, Bandyopadhyay U: Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective. Biochem Pharmacol 2020; 180: 114147","DOI":"10.1016\/j.bcp.2020.114147"},{"key":"10.3238\/arztebl.m2022.0244_ref36","doi-asserted-by":"crossref","unstructured":"Rauschert C, Seitz N-N, Olderbak S, Pogarell O, Dreischulte T, Kraus L: Abuse of non-opioid analgesics in Germany: prevalence and associations among self-medicated users. Front Psychiatry 2022; 13: 864389","DOI":"10.3389\/fpsyt.2022.864389"},{"key":"10.3238\/arztebl.m2022.0244_ref37","unstructured":"BAH \u2013 Bundesverband der Arzneimittel-Hersteller: Der Arzneimittelmarkt in Deutschland. Zahlen und Fakten aus 2020. www.bah-bonn.de\/publikationen\/zahlen-fakten\/ (last accessed on 21 June 2022)."},{"key":"10.3238\/arztebl.m2022.0244_ref38","doi-asserted-by":"crossref","unstructured":"Reinecke H, Weber C, Lange K, Simon M, Stein C, Sorgatz H: Analgesic efficacy of opioids in chronic pain: recent meta-analyses. Br J Pharmacol 2015; 172: 324\u201333","DOI":"10.1111\/bph.12634"},{"key":"10.3238\/arztebl.m2022.0244_ref39","doi-asserted-by":"crossref","unstructured":"Buth S, Holzbach R, Martens MS, Neumann-Runde E, Meiners O, Verthein U: Problematic medication with benzodiazepines, \u201cZ-drugs\u201d, and opioid analgesics\u2014an analysis of national health insurance prescription data from 2006\u20132016. Dtsch Arztebl Int 2019; 116: 607\u201314","DOI":"10.3238\/arztebl.2019.0607"},{"key":"10.3238\/arztebl.m2022.0244_ref40","unstructured":"Sozialdemokratische Partei Deutschlands (SPD), B\u00dcNDNIS 90 \/ DIE GR\u00dcNEN, Freie Demokraten (FDP): Mehr Fortschritt wagen. B\u00fcndnis f\u00fcr Freiheit, Gerechtigkeit und Nachhaltigkeit. Koalitionsvertrag 2021 \u2013 2025 zwischen der Sozialdemokratischen Partei Deutschlands (SPD), B\u00dcNDNIS 90 \/ DIE GR\u00dcNEN und den Freien Demokraten (FDP) www.bundesregierung.de\/resource\/blob\/974430\/1990812\/04221173eef9a6720059cc353d759a2b\/2021-12-10-koav2021-data.pdf?download=1 (last accessed on 18 March 2022)."},{"key":"10.3238\/arztebl.m2022.0244_ref41","doi-asserted-by":"crossref","unstructured":"Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO: The Fagerstr\u00f6m test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991; 86: 1119\u201327","DOI":"10.1111\/j.1360-0443.1991.tb01879.x"},{"key":"10.3238\/arztebl.m2022.0244_ref42","doi-asserted-by":"crossref","unstructured":"Foulds J, Veldheer S, Yingst J, et al.: Development of a questionnaire for assessing dependence on electronic cigarettes among a large sample of ex-smoking E-cigarette users. Nicotine Tob Res 2015; 17: 186\u201392","DOI":"10.1093\/ntr\/ntu204"},{"key":"10.3238\/arztebl.m2022.0244_ref43","unstructured":"Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG: AUDIT. The Alcohol Use Disorders Identification Test. Guidelines for use in primary care. Geneva: World Health Organization 2001."},{"key":"10.3238\/arztebl.m2022.0244_ref44","doi-asserted-by":"crossref","unstructured":"Gossop M, Darke S, Griffiths P, et al.: The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 1995; 90: 607\u201314","DOI":"10.1046\/j.1360-0443.1995.9056072.x"},{"key":"10.3238\/arztebl.m2022.0244_ref45","unstructured":"Watzl H, Rist F, H\u00f6cker W, Miehle K: Entwicklung eines Fragebogens zur Erfassung von Medikamentenmi\u00dfbrauch bei Suchtpatienten. In: Heide M, Lieb H (eds.): Sucht und Psychosomatik. Beitr\u00e4ge des 3 Heidelberger Kongresses. Bonn: Nagel 1991; 123\u201339."},{"key":"10.3238\/arztebl.m2022.0244_ref46","unstructured":"Statistisches Bundesamt: Tabelle 12411\u20130013: Bev\u00f6lkerung: Bundesl\u00e4nder, Stichtag, Geschlecht, Altersjahre. Verf\u00fcgbarer Zeitraum: 31.12.1967 \u2013 31.12.2020. www-genesis.destatis.de\/genesis\/\/online?operation=table&code=12411\u20130013&bypass=true&levelindex=1&levelid=1647608392301#abreadcrumb (last accessed on 31 December 2020)."},{"key":"10.3238\/arztebl.m2022.0244_ref47","unstructured":"Heeringa SG, West BT, Berglund PA: Applied survey data analysis. NewYork: Chapman and Hall\/CRC 2017."},{"key":"10.3238\/arztebl.m2022.0244_ref48","doi-asserted-by":"crossref","unstructured":"Hackshaw A, Morris JK, Boniface S, Tang JL, Milenković D: Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports. BMJ\u00a02018; 360: j5855","DOI":"10.1136\/bmj.j5855"},{"key":"10.3238\/arztebl.m2022.0244_ref49","unstructured":"Schaller K, Kahnert S: Alkoholatlas Deutschland 2017. Pabst Science Publishers 2017."},{"key":"10.3238\/arztebl.m2022.0244_ref50","unstructured":"Beckmann K, Glemser A, Heckel C, et al.: Demographische Standards : eine gemeinsame Empfehlung des ADM, Arbeitskreis Deutscher Markt- und Sozialforschungsinstitute e.V., der Arbeitsgemeinschaft Sozialwissenschaftlicher Institute e.V. (ASI) und des Statistischen Bundesamtes. Wiesbaden 2016."},{"key":"10.3238\/arztebl.m2022.0244_ref51","unstructured":"Wittchen HU, Beloch E, Garczynski E, et al.: M\u00fcnchener Composite International Diagnostic Interview (M-CIDI), Paper-pencil 2.2, 2\/95. M\u00fcnchen: Max-Planck-Institut f\u00fcr Psychiatrie, Klinisches Institut 1995."},{"key":"10.3238\/arztebl.m2022.0244_ref52","unstructured":"B\u00fchringer G, Augustin R, Bergmann E, et al.: Alkoholkonsum und alkoholbezogene St\u00f6rungen in Deutschland. Baden-Baden: Nomos 2000."},{"key":"10.3238\/arztebl.m2022.0244_ref53","doi-asserted-by":"crossref","unstructured":"Conigrave KM, Hall WD, Saunders JB: The AUDIT questionnaire: choosing a cut-off score. Addiction 1995; 90: 1349\u201356","DOI":"10.1111\/j.1360-0443.1995.tb03552.x"},{"key":"10.3238\/arztebl.m2022.0244_ref54","unstructured":"Rist F, Scheuren B, Demmel R, Hagen J, Aulhorn I: Der M\u00fcnsteraner Alcohol Use Disorders Identification Test (AUDIT-G-M). In: Gl\u00f6ckner-Rist A, Rist F, K\u00fcfner H (eds.): Elektronisches Handbuch zu Erhebungsinstrumenten im Suchtbereich (EHES) Version 3. Mannheim: Zentrum f\u00fcr Umfragen, Methoden und Analysen 2003."},{"key":"10.3238\/arztebl.m2022.0244_ref55","doi-asserted-by":"crossref","unstructured":"Breslau N, Johnson EO: Predicting smoking cessation and major depression in nicotine-dependent smokers. Am J Public Health 2000; 90: 1122","DOI":"10.2105\/AJPH.90.7.1122"},{"key":"10.3238\/arztebl.m2022.0244_ref56","doi-asserted-by":"crossref","unstructured":"Morean ME, Krishnan-Sarin S, Sussman S, et al.: Psychometric evaluation of the E-cigarette dependence scale. Nicotine Tob Res 2019; 21: 1556\u201364","DOI":"10.1093\/ntr\/ntx271"},{"key":"10.3238\/arztebl.m2022.0244_ref57","doi-asserted-by":"crossref","unstructured":"Gabler S, Hoffmeyer-Zlotnik J, Krebs D: Gewichtung in der Umfragepraxis. Opladen: Westdeutscher Verlag 1994","DOI":"10.1007\/978-3-663-08044-2"},{"key":"10.3238\/arztebl.m2022.0244_ref58","unstructured":"Lohr SL: Sampling. Design and analysis. 3rd edition. Boca Raton: CRC Press 2022."},{"key":"10.3238\/arztebl.m2022.0244_ref59","doi-asserted-by":"crossref","unstructured":"Little RJ, Lewitzky S, Heeringa S, Lepkowski J, Kessler RC: Assessment of weighting methodology for the National Comorbidity Survey. Am J Epidemiol 1997; 146: 439\u201349","DOI":"10.1093\/oxfordjournals.aje.a009297"},{"key":"10.3238\/arztebl.m2022.0244_ref60","unstructured":"Robert Koch-Institut: Daten und Fakten: Ergebnisse der Studie \u201eGesundheit in Deutschland aktuell 2012\u201c. Berlin 2014."},{"key":"10.3238\/arztebl.m2022.0244_ref61","unstructured":"Gelman A, Carlin J: Poststratification and weighting adjustments. In: Groves RM, Eltinge JL, Little RJA (eds.): Survey nonresponse. New York: John Wiley and Sons 2002; 289\u2013303."},{"key":"10.3238\/arztebl.m2022.0244_ref62","unstructured":"Statistisches Bundesamt: Bev\u00f6lkerungsfortschreibung auf Grundlage des Zensus 2011 \u2013 Fachserie 1 Reihe 1.3 \u2013 2020. www.destatis.de\/DE\/Themen\/Gesellschaft-Umwelt\/Bevoelkerung\/Bevoelkerungsstand\/Publikationen\/Downloads-Bevoelkerungsstand\/bevoelkerungsfortschreibung-2010130207005.html (last accessed on 21 June 2022)."},{"key":"10.3238\/arztebl.m2022.0244_ref63","unstructured":"Baumann H, Schulz S, Thiesen S: ALLBUS 2018 \u2013 Variable Report [Studien-Nr. 5270. Diese Dokumentation bezieht sich auf den Datensatz in Version 2.0.0, doi: 10.4232\/1.13250]."}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2022.0244","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T08:31:41Z","timestamp":1659429101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2022.0244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,8]]},"references-count":63,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2022.0244","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,8]]}}}